CYNTHIA CHERRY: Open Payments
NPI 1760811897 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 67 payments from 13 companies in 2025. Trend: 2023 $262 · 2024 $813 · 2025 $1,535
Food & beverage: $1,435Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $577 |
| Regeneron Healthcare Solutions, Inc. | 7 | $209 |
| GlaxoSmithKline, LLC. | 18 | $193 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 4 | $99 |
| Insmed, Inc. | 4 | $76 |
| Grifols USA, LLC | 4 | $74 |
| Verona Pharma, Inc. | 3 | $69 |
| Electromed, Inc. | 4 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: DUPIXENT, AIRSUPRA, BREZTRI, NUCALA, FASENRA, TRELEGY ELLIPTA, Prolastin-C Liquid, Ohtuvayre.
Industry payments across NC — which companies pay providers there.
